Inflammatory bowel disease: No association between allele combinations of the interleukin (IL) Iβ and IL-I receptor antagonist gene polymorphisms

European Journal of Clinical Investigation

Volumn 28, Issue 3, 1998, Pages 214-219

  Hacker, U T ^a,b   Bidlingmaier, C ^a,b   Gomolka, M ^a,b   Keller, E ^a,b   Eigler, A ^a,b   Hartmann, G ^a,b   Folwaczny, Chr ^a,b   Fricke, H ^a,b   Albert, E ^a,b   Loeschke, K ^a,b   Endres, S ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytokine; Immunogenetics; Inflammatory bowel disease; Interleukin 1 ; Polymorphism; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CROHN DISEASE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ALLELES; BASE SEQUENCE; COLITIS, ULCERATIVE; CROHN DISEASE; DNA PRIMERS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS;

EID: 15444357408     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00277.x     Document Type: Article

References (25)

1. Satsangi J, Jewell DP, Rosenberg WM, Bell JI. Genetics of inflammatory bowel disease. Gut 1994; 35: 696-700.
2. Yang H, Rotter JI, Toyoda H et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993; 92: 1080-4.
3. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 1989; 96: 1016-20.
4. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TIA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84-8.
5. Tysk C, Lindberg E, Jarnerot G, Floderus MB. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990-6.
6. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
7. Louis E, Satsangi J, Roussomoustakaki M et al. Cytokine gene polymorphisms in inflammatory bowel disease. Guf 1996; 39: 705-10.
8. Hacker UT, Gomolka M, Keller E et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997; 40: 623-7.
9. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-4.
10. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450.
11. Bailly S, Di Giovine FS, Duff GW. Polymorphic tandem repeat region in interleukin-1a intron 6. Hum Genet 1993; 91: 85-6.
12. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38: 221-8.
13. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
14. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
15. Bioque G, Crusius JB, Koutroubakis I et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-IRa) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379-83.
16. Miller SA, Dykes DD, Polesky HF, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
17. Pociot F, Ronningen KS, Bergholdt R et al. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes - evidence for polygenicity in man. Danish Study Group Diabetes in Childhood Autoimmunity 1994; 19: 169-78.
18. Plevy SE, RTS.Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease - associated haplotype on chromosome 6. Gastroenterology 1996; 110: 1053-60.
19. Toyoda H, Wang SJ, Yang HY et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104: 741-8.
20. Satsangi J, Welsh KI, Bunce M et al. Contribution of genes of the mayor histocompatibility complex and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-7.
21. Naom I, Lee J, Ford D et al. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet 1996; 59: 226-33.
22. Casini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154: 2434-40.
23. Ferretti M, Casini RV, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994; 94: 449-53.
24. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992; 103: 65-71.
25. Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-53.